2020 annual financial data
GT Biopharma 2020 Operating margin
GT Biopharma 2020 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -6,764,000 USD and net income was -28,296,000 USD.
Operating cash flow was -7,262,000 USD.
Get free GT Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -6,764,000 USD
- Net income
- -28,296,000 USD
- Operating cash flow
- -7,262,000 USD